CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. Net Cash Provided by (Used in) Continuing Operations
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. (CBIH) reported Net Cash Provided by (Used in) Continuing Operations of -$123.80 thousand for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-16.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2026-04-16
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2026-02-28 was -$14.60K.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2025-11-30 was -$5.49K.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2025-08-31 was -$103.71K, a 441.01% decline year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for the quarter ending 2025-05-31 was -$144.31K, a 182.73% decline year-over-year.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for fiscal 2025 was -$329.63K, a 168.76% decline from fiscal 2024.
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. net cash provided by (used in) continuing operations for fiscal 2024 was $479.38K.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2026-02-28 | -$14.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-16 | -$20.09K derived: sum of 2 quarters · filed 2026-04-16 | -$123.80K 10-Q · filed 2026-04-16 | -$268.11K derived: sum of 4 quarters · filed 2026-04-16 |
| 2025-11-30 | -$5.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-19 | -$109.20K 10-Q · filed 2026-02-19 | -$253.52K derived: sum of 3 quarters · filed 2026-02-19 | |
| 2025-08-31 | -$103.71K 10-Q · filed 2025-10-22 | -$248.02K derived: sum of 2 quarters · filed 2025-10-22 | ||
| 2025-05-31 | -$144.31K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-22 | -$329.63K 10-K · filed 2025-09-22 | ||
| 2025-02-28 | -$185.31K 10-Q/A · filed 2025-05-09 | |||
| 2024-08-31 | $30.41K 10-Q · filed 2024-10-21 | $204.85K derived: sum of 2 quarters · filed 2024-10-21 | $213.93K derived: sum of 3 quarters · filed 2024-10-21 | |
| 2024-05-31 | $174.44K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-16 | $183.51K derived: sum of 2 quarters · filed 2024-09-16 | $479.38K 10-K · filed 2024-09-16 | |
| 2024-02-29 | $9.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-22 | $304.94K 10-Q · filed 2024-04-22 | ||
| 2023-11-30 | $295.87K 10-Q · filed 2024-01-25 |